Protara Therapeutics, Inc. (TARA) Net income 2016–2025
Protara Therapeutics, Inc. (TARA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$57.4MFY2025 · since FY2016: -$28.5M → -$57.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$57.4M | -28.7% |
| FY2024 | -$44.6M | -10.4% |
| FY2023 | -$40.4M | +38.7% |
| FY2022 | -$66.0M | -39.6% |
| FY2021 | -$47.3M | -39.1% |
| FY2020 | -$34.0M | -333.9% |
| FY2019 | -$7.8M | +62.2% |
| FY2018 | -$20.7M | +30.8% |
| FY2017 | -$30.0M | -5.0% |
| FY2016 | -$28.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice